DarioHealth (DRIO) Cost of Revenue (2016 - 2025)
DarioHealth filings provide 12 years of Cost of Revenue readings, the most recent being $2.4 million for Q4 2025.
- On a quarterly basis, Cost of Revenue fell 28.66% to $2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.7 million, a 29.62% decrease, with the full-year FY2025 number at $9.7 million, down 29.62% from a year prior.
- Cost of Revenue hit $2.4 million in Q4 2025 for DarioHealth, up from $2.0 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $5.5 million in Q4 2021 to a low of $2.0 million in Q1 2021.
- Median Cost of Revenue over the past 5 years was $3.5 million (2023), compared with a mean of $3.6 million.
- Biggest five-year swings in Cost of Revenue: soared 257.94% in 2021 and later crashed 43.82% in 2025.
- DarioHealth's Cost of Revenue stood at $5.5 million in 2021, then dropped by 25.6% to $4.1 million in 2022, then dropped by 14.55% to $3.5 million in 2023, then decreased by 2.35% to $3.4 million in 2024, then dropped by 28.66% to $2.4 million in 2025.
- The last three reported values for Cost of Revenue were $2.4 million (Q4 2025), $2.0 million (Q3 2025), and $2.4 million (Q2 2025) per Business Quant data.